Dan Leonard, longtime leader of the National Pharmaceutical Council who became CEO of the Association for Accessible Medicines in September, discusses the impact of generic medications on health care, and the challenges and opportunities facing the industry. Among the issues addressed are generics’ role in treating COVID-19 patients, the emergence of biosimilars, and the Medicaid generics penalty.

You must be logged in to post a comment Login